日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential

CHD1L 在癌症及其他领域中的作用:结构、致癌功能和治疗潜力

Clune, Sophia; Awolade, Paul; Esquer, Hector; Zhou, Qiong; LaBarbera, Daniel V

Breast cancer cell coculture induces normal lung fibroblast transition to CAFs, promoting tumor cell dormancy and therapy resistance

乳腺癌细胞共培养可诱导正常肺成纤维细胞向癌相关成纤维细胞(CAFs)转化,从而促进肿瘤细胞休眠和治疗耐药性。

Klosowski, Marika L; Cronise, Kathryn E; Palmer, Eric P; McAuliffe, Kelly; Stratton, Claire; Sparks, Kelsie; Malmstrom, Kendall T; Knott-Byars, Gwyneth; Zhou, Qiong; Esquer, Hector; LaBarbera, Daniel V; Regan, Daniel P

Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer.

OTI-611 通过靶向抑制 CHD1L 来重编程化疗和靶向治疗诱导的细胞周期阻滞,并抑制增殖,从而在乳腺癌和结直肠癌中产生协同抗肿瘤作用

Esquer Hector, Zhou Qiong, LaBarbera Daniel V

EXTH-145. Chimeric Antigen Receptor-Engineered Extracellular Vesicles from Human Stem Cell-Derived Neutrophils for Glioblastoma Therapy

EXTH-145. 嵌合抗原受体工程化人干细胞来源中性粒细胞胞外囊泡用于胶质母细胞瘤治疗

Li, Linfeng; Zhou, Qiong; Voss, Ty C; Quick, Kevin L; LaBarbera, Daniel V; Michaelides, Loizos; Esmonde, Colin; Sun, Li; Chang, Yun; Zeng, Changchun; Quinones-Hinojosa, Alfredo; Xiaoping, Bao; Li, Yan

Validation of ferroptosis in canine cancer cells to enable comparative oncology and translational medicine

验证犬癌细胞中的铁死亡,以促进比较肿瘤学和转化医学的发展

Chatterji, Priya; Xing, Gang; Furst, Laura; Dave, Krishna; Zhou, Qiong; LaBarbera, Daniel V; Thamm, Douglas H; Eaton, John K; Wawer, Mathias J; Viswanathan, Vasanthi S

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer

AST-487抑制膀胱癌中RET激酶驱动的TERT表达

Agarwal, Neeraj; Zhou, Qiong; Arya, Deepak; Rinaldetti, Sébastien; Duex, Jason; LaBarbera, Daniel V; Theodorescu, Dan

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers

779例晚期分化型和未分化型甲状腺癌的基因分析

Pozdeyev, Nikita; Gay, Laurie M; Sokol, Ethan S; Hartmaier, Ryan; Deaver, Kelsi E; Davis, Stephanie; French, Jena D; Borre, Pierre Vanden; LaBarbera, Daniel V; Tan, Aik-Choon; Schweppe, Rebecca E; Fishbein, Lauren; Ross, Jeffrey S; Haugen, Bryan R; Bowles, Daniel W

Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme

鉴定基孔肯雅病毒nsP1 RNA加帽酶的小分子抑制剂

Feibelman, Kristen M; Fuller, Benjamin P; Li, Linfeng; LaBarbera, Daniel V; Geiss, Brian J

An improved high yield total synthesis and cytotoxicity study of the marine alkaloid neoamphimedine: an ATP-competitive inhibitor of topoisomerase IIα and potent anticancer agent.

海洋生物碱新两性霉素的改进高产率全合成及细胞毒性研究:一种拓扑异构酶 IIα 的 ATP 竞争性抑制剂和强效抗癌剂

Li Linfeng, Abraham Adedoyin D, Zhou Qiong, Ali Hadi, O'Brien Jeremy V, Hamill Brayden D, Arcaroli John J, Messersmith Wells A, LaBarbera Daniel V

Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibition

新两性霉素通过ATP竞争性抑制来规避甲萘醌增强的DNA拓扑异构酶IIα活性。

Ponder, Jessica; Yoo, Byong Hoon; Abraham, Adedoyin D; Li, Qun; Ashley, Amanda K; Amerin, Courtney L; Zhou, Qiong; Reid, Brian G; Reigan, Philip; Hromas, Robert; Nickoloff, Jac A; LaBarbera, Daniel V